Table 2

Methylation of SYN III promoter cytosine 8 and 20 in 51 blood samples representing controls and patients with schizophrenia.

Unaffected Control Number

Methylation of cytosine number 8 and 20

8

20


C1

○/●

○/●


C2

○/●

○/●


C3

○/●

○/●


C4

○/●

○/●


C5

○/●

○/●


C6

○/●

○/●


C7

○/●

○/●


C8

○/●


C9

○/●


C10

○/●

○/●


C11

○/●

○/●


C12

○/●

○/●


C13

○/●


C14

○/●

○/●


C15

○/●


C16

○/●

○/●


C17

○/●

○/●


C18

○/●

○/●


C19

○/●

○/●


C20

○/●


C21

○/●


C22

○/●


C23

○/●

○/●


C24

○/●


C25

○/●

○/●


C26

○/●

○/●


C27

○/●


C28

○/●

○/●


C29

○/●

○/●


C30

○/●

○/●


C31

○/●

○/●


Schizophrenia Patient Number

Methylation of cytosine number 8 and 20


8

20


SZ1

○/●

○/●


SZ2

○/●

○/●


SZ3

○/●

○/●


SZ4

○/●

○/●


SZ5

○/●

○/●


SZ6

○/●

○/●


SZ7

○/●

○/●


SZ8

○/●

○/●


SZ9

○/●

○/●


SZ10

○/●

○/●


SZ11

○/●

○/●


SZ12

○/●

○/●


SZ13

○/●

○/●


SZ14

○/●

○/●


SZ15

○/●

○/●


SZ16

○/●


SZ17

○/●

○/●


SZ18

○/●

○/●


SZ19

○/●


SZ20

○/●

○/●


Totals for complete versus partial methylation of cytosine 20


Controls

Patients


Complete Methylation

9

2


Partial Methylation

22

18


Murphy et al. BMC Medical Genetics 2008 9:115   doi:10.1186/1471-2350-9-115

Open Data